---
schema_version: "secwatch.filing_event.v1"
accession: "0001140859-26-000012"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:31:27.857448+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Cencora reorganizes segments; explores strategic alternatives for MWI Animal Health, Profarma, U.S. Consulting Services

## Summary
- New segments: U.S. Healthcare Solutions, International Healthcare Solutions, and Other.
- Other includes MWI Animal Health, Profarma, U.S. Consulting Services, and legacy Pharmalex components under strategic review.
- Segment reporting change effective Q1 FY2026; historical segment data in 2025 10-K revised but consolidated financials unchanged.
- No updates on events after November 25, 2025; first quarter FY2026 10-Q filed February 4, 2026.

## SEC filing metadata
- accession: 0001140859-26-000012
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000114085926000012/0001140859-26-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000114085926000012/cor-20260210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140859-26-000012
- JSON: https://secwatch.observer/filing/0001140859-26-000012.json
- Plain text: https://secwatch.observer/filing/0001140859-26-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.